Xylogenics Overview

  • Founded
  • 2008
  • Status
  • Private
  • Employees
  • 7
  • Latest Deal Type
  • Conv. Debt
  • Latest Deal Amount
  • $525K
Latest Deal Amount

Xylogenics General Information


Provider of a yeast genomics platform. The company is engaged in the the engineering of modified yeast microorganisms to synthesize commercial chemicals.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Primary Office
  • 351 West 10th Street
  • Indianapolis, IN 46202
  • United States
+1 (317) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Xylogenics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Convertible Debt 20-Dec-2010 $525K 00000 Completed Startup
To view Xylogenics’s complete valuation and funding history, request access »

Xylogenics Executive Team (5)

Name Title Board Seat Contact Info
Joshua Heyen Ph.D Chief Executive Officer, President & Co-Founder
Matt Kelker Ph.D Chief Scientific Officer
Cary Woods Co-Founder
To view Xylogenics’s complete executive team members history, request access »

Xylogenics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial